The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FDA 'No Objection' ruling on new product

21 Jul 2010 07:00

RNS Number : 6497P
PureCircle Limited
21 July 2010
 



PureCircle receives FDA GRAS "No Objection" for new SG95 stevia product

 

PureCircle (LSE: PURE), the world's leading producer of high purity stevia products, is pleased to announce that the US Food and Drug Administration (FDA) has issued a No Objection letter for the use of PureCircle's SG95 product as a Food and Beverage ingredient in the USA. This will enable PureCircle to offer a wider and more flexible array of stevia solutions, helping to further accelerate stevia adoption in the important USA market.

 

PureCircle's high purity SG95 product is a further example of the company's leadership in innovation. Along with seven previously approved steviol glycosides, SG95 includes two new steviol gylcosides, Rebaudioside D and Rebaudioside F, both of which are receiving GRAS No Objection for the first time. The new high purity sweetener delivers great taste and consistency as well as pricing well below sugar. The product is ideally suited for applications formulated with both sugar and SG95 to achieve a low cost solution to partial sugar and calorie reduction and provide further incentive to application development. Together with PureCircle's successful high purity Reb A 97, SG95 will provide customers with an expanded range of options to improve products across their portfolios. With GRAS affirmation, PureCircle is prepared for immediate commercialisation of SG95.

 

Magomet Malsagov, CEO and Managing Director of PureCircle, said: "The launch of SG95 is a very exciting development for PureCircle in the United States with considerable future potential in global markets. Expanded use of sweet glycosides from the stevia plant in a highly consistent blend provides both formulation and economic benefits to our customers. Our Reb A 97 continues to play a major role in our portfolio particularly as our investments yield continued efficiencies that will be shared with our customers. Now SG95 will provide an additional compelling product in many applications. We are proud to continue to be at the forefront of innovation to help mainstream a better sweet choice for consumers. "

 

For more information:

PureCircle Limited (www.purecircle.com)

Jason Hecker, Group Marketing Director

(847) 630-0374

Magomet Malsagov, CEO

+60 1 2388 8049

William Mitchell, CFO 

+44 7974 005 163 

Westport Communications

+44 20 7065 2690

Alan Frame

alan@westportcomms.com

Jeanette Bishop

RFC Corporate Finance Ltd

+61 8 9480 2500 

Stephen Allen

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
REAPGURPMUPUGQU
Date   Source Headline
3rd Oct 20129:41 amRNSHolding(s) in Company
3rd Oct 20129:11 amRNSDirector/PDMR Shareholding
3rd Oct 20127:00 amRNSLTIP Options - Options Issued to Directors
1st Oct 20127:00 amRNSDirector/PDMR Shareholding
28th Sep 20127:00 amRNSAnnouncement of New Agreements
11th Sep 20127:00 amRNSFinal Results
6th Sep 20127:00 amRNSAnnouncement of Prelims & Investor Conference Call
9th Aug 20127:00 amRNSCompletion of Share Placement & Board Appointment
7th Aug 20127:00 amRNSExpansion of Executive Management Team
1st Aug 20127:00 amRNSPlacing of £20 million
26th Jul 20129:09 amRNSHolding(s) in Company
10th Jul 20127:00 amRNSLTIP Options
9th Jul 20128:50 amRNSHolding(s) in Company
9th Jul 20127:00 amRNSPre Close Period Update 2H FY 2012
24th Apr 20129:32 amRNSChange of Significant Shareholding
11th Apr 20127:00 amRNSNominated Adviser to Change Name
3rd Apr 20127:00 amRNSNew Significant Shareholding
30th Mar 20127:00 amRNSLTIP Options - Exercise by Directors
29th Mar 20127:00 amRNSInterim Results for the six months ended 31 Dec 11
9th Mar 20127:00 amRNSAnnouncement of Interim Results & Investor Call
1st Feb 20127:00 amRNSRe-organisation of Joint Broker
30th Jan 20121:45 pmRNSDirector/PDMR Shareholding
12th Jan 20127:00 amRNSTrading Update - H1 FY 2012
16th Dec 20117:00 amRNSQuarterly Stevia Market Update
14th Dec 20119:57 amRNSResult of AGM
18th Nov 20117:00 amRNSNotice of AGM and Annual Report
14th Nov 20117:00 amRNSRegulatory Approval for Stevia in the EU
11th Nov 20118:47 amRNSIssue of new shares in respect of the LTIP
3rd Nov 20118:43 amRNSChange of Significant Shareholding
30th Sep 20117:00 amRNSNotification of a Major Interest
28th Sep 20117:00 amRNSChange of Significant Shareholding
27th Sep 20119:26 amRNSDirector/PDMR Shareholding
19th Sep 20117:00 amRNSFinal Results
15th Sep 20117:00 amRNSLaunch of New Sweetener
12th Sep 20117:00 amRNSPreliminary Results and Investor Conference Call
7th Sep 20117:00 amRNSOperational Update
22nd Jul 20117:00 amRNSLTIP Options
13th Jul 20117:00 amRNSHigh Purity Stevia Market Update
8th Jul 20117:00 amRNSFurther regulatory approval recommendations
6th Jul 20117:00 amRNSTrading Update
5th Jul 20117:00 amRNSRecommendation for EU Approval
1st Jul 20117:00 amRNSPureCircle Announces Global Distribution Agreement
17th Jun 20118:44 amRNSChange of Significant Shareholding
17th Jun 20117:00 amRNSTrading Update
18th Apr 20118:23 amRNSDirector/PDMR Shareholding
7th Apr 20117:00 amRNSChange of Significant Shareholding
30th Mar 20117:00 amRNSMATERIAL CONTRACT EXTENSION
25th Mar 20118:48 amRNSDirector/PDMR Shareholding
21st Mar 20117:00 amRNSHalf Yearly Report
15th Mar 20117:00 amRNSInvestor Conference Call - Correction of Timing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.